NATCO Pharma Limited
₹1,376.55
INR+9.60(+0.70%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹24763.75 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹22545.55 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
15.12
Forward P/E
Price to Earnings ratio based on forecasted earnings
33.50
PEG Ratio
Price/Earnings to Growth ratio
33.50
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
5.69
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
86.78%
Operating Margin
Operating income as a percentage of revenue
55.83%
Return on Equity
Net income as a percentage of shareholders' equity
23.72%
Revenue (TTM)
Total revenue over trailing 12 months
₹4349.00 Cr+19.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹2184.70 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹91.47+59.099999999999994%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1849.20 Cr
Total Debt
Total short-term and long-term debt
₹371.20 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
6.34%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹724.2 - ₹1639
Beta
Measure of stock's volatility compared to the market
0.51
Shares Outstanding
Total number of shares issued by the company
₹17.91 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.85%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.41%
Payout Ratio
Percentage of earnings paid as dividends
10.39%